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Integrated primary care assimilates psychologists into the primary care setting, thus 
improving health outcomes and physician satisfaction. Neuropsychology has also begun to 
assimilate into primary care, as neurocognitive impairment is a correlate of many medical 
disorders. Subjective cognitive decline (SCD), a common complaint among older adults, is an 
increasingly recognized warning sign of non-normative cognitive aging. These patients typically 
present first to their primary care providers who may play a critical role in the early detection of 
cognitive impairment. Given the growing awareness about cognitive health and disability, the 
importance of neuropsychological assessment as a standard component of integrated care has 
been recognized by providers. Thus, the purpose of this study is to examine the efficacy and 
feasibility of neuropsychological services, for memory concerns, in a community primary care 
setting. The study also explored the relationship between SCD and performance on 
neurocognitive measures and satisfaction levels for both patient participants and medical 
providers. A total of 16 patient participants completed the study. On average, patients were in 
their late-60’s and mostly female and Caucasian. Participants completed a brief interview, 
neurocognitive evaluation, self-report measures of SCD and mood, and satisfaction survey. 
Results did not reveal significant correlations between SCD and neurocognitive performance. 
Significantly more referrals were made to the onsite neurocognitive clinic, than were made for 
outside services in a nine-month period preceding the described program. Patients referred to the 
onsite clinic were also significantly more likely to have an accessible report located in their EMR 






clinic services. Results suggest that a clinic of this nature has promising benefits and is well-
liked by both patients and providers, though barriers related to full utilization of services remain 
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CHAPTER 1: INTRODUCTION 
 
Integrated Primary Care (IPC) assimilates psychologists into the primary care setting to 
collaborate and work alongside primary care providers (James, 2006). Traditionally, primary 
care refers to the provision of integrated and accessible health care services by providers who 
address a large majority of personal health care needs, develop a sustained partnership with 
patients, and practice in the context of family and community. Behavioral health typically refers 
to the broad area of mental health and substance abuse conditions as well as health behaviors 
(including their influence to chronic medical illnesses), life stressors, and physical symptoms 
related to stress. Therefore, primary care and behavioral health integration is defined as “the care 
that results from a practice team of primary care and behavioral health clinicians, working 
together with patients and families, using a systematic and cost-effective approach to provide 
patient-centered care for a defined population,” (Peek, 2013; Vogel, Kanzler, Aikens, & Goodie, 
2017). While IPC is a relatively new field of practice, it is constantly evolving to adapt to the 
needs of the patient-centered medical home. Given its early stages, research in IPC remains 
limited; however, current research has explored common referral questions related to depression, 
anxiety, and Attention-Deficit/Hyperactivity Disorder (Craig, 2015), and more recently, the role 
of neuropsychological assessment in primary care (Kubu, Ready, Festa, Roper, & Pliskin, 2016; 
Michels, Tiu, & Graver, 2010).  
Changes in an individual’s cognitive abilities can be seen across the lifespan. Broadly, 
cognitive abilities decline between one and two standard deviations between twenty and seventy 






cognitive decline differs among individuals and can generally be delineated into normative, or 
non-pathological cognitive aging, and pathological cognitive aging (Deary & Der, 2005; Park, 
Polk, Mikels, Taylor, & Marshuetz, 2001; Raz et al., 2005). However, individual trajectories of 
cognitive aging can vary widely and are affected by numerous lifestyle and idiographic factors 
including components such as diet, neurobiological changes, genetics, overall general health, 
cerebrovascular factors such as atherosclerotic disease, and biological processes such as 
inflammation, and other medical factors (Deary et al., 2009). Clinical neuropsychology has 
emerged as one strategy to characterize the broad heterogeneity in the presentation, etiology, and 
prognosis of cognitive impairment in clinical populations of older adults. 
Clinical Neuropsychology 
 Clinical neuropsychology is an “applied science concerned with the behavioral 
expression of brain dysfunction” (Lezak, 2004, p. 7). In addition, the National Academy of 
Neuropsychology’s (NAN) definition of a clinical neuropsychologist, stipulates that a clinical 
neuropsychologist possesses expertise in brain–behavior relationships (Barth et al., 2003). 
Clinical neuropsychologists use this knowledge in the assessment, diagnosis, treatment, and 
rehabilitation of individuals with neurological, medical, or neurodevelopmental conditions, as 
well as other cognitive and learning disorders (Barth et al., 2003; Lezak, 2004). In order to 
evaluate an individual’s neurocognitive strengths and weaknesses, as well as components of 
emotional and behavioral functioning, neuropsychological assessment utilizes a combination of 
psychological, neurological, cognitive, behavioral, and physiological tests. An individual’s 






understand the relationship to normal and abnormal cognitive and/or central nervous system 
functioning (Barth et al., 2003; Lezak, 2004).   
The goals and benefits associated with neuropsychological assessment may differ as a result 
of the referral question. For example, the goal of establishing probable localization, 
lateralization, and etiology of a brain lesion may be best suited to aid with surgical interventions 
for epilepsy surgery or deep brain stimulation, whereas identifying an individual’s 
neuropsychological and neurobehavioral profile may most aid in distinguishing between normal 
cognitive aging and atypical cognitive aging or between varieties of dementia (Lezak, 2004; 
Michels et al., 2010). Broadly speaking, though, neuropsychologists assess brain function and 
impairment by drawing inferences from performance on objective test measures. Tests that 
examine neuropsychological functioning are often able to identify subtle cognitive deficits that 
may not be detected by electro-physiological or imaging methods. Performance on these 
assessment measures are subsequently used to inform clinical decision making, planning, and 
monitoring the outcomes and effects of treatment (Lezak, 2004; Michels et al., 2010). 
Additionally, the assessment of an individual’s cognitive capacities and potential deficits aids in 
elucidating real-world resources and limitations. Neuropsychological services may also function 
to improve an individual’s overall quality of life through cognitive rehabilitation (cognitive 
skills, judgment, and decision making). A review of the literature has demonstrated benefit in 
treating these deficits among stoke and traumatic brain injury (TBI) (Cicerone et al., 2005; 






Integrated Primary Care 
As noted above, IPC works to assimilate psychologists into the primary care setting, so 
that they are better able to collaborate and work alongside primary care providers (James, 2006). 
Integrated primary care and its subsequent benefits have been illustrated with a five-component 
model that includes components of collaboration, access to care, satisfaction, quality treatment, 
and reduced costs (James & O’Donohue, 2009).  
Collaboration. Integrated primary care aims to create an environment that is conducive to 
collaboration of providers. This collaboration is fostered by co-locating primary care and mental 
health in the same facility, as well as encouraging an integrated treatment approach (James, 
2006; James & O’Donohue, 2009). The aim of IPC treatment is to develop one comprehensive 
treatment plan in which providers contribute their area of expertise (A. Blount, 2003). The 
emphasis on collaboration in IPC is in accordance with the movement towards a patient-centered 
medical home (PCMH) as supported by The Agency for Healthcare Research and Quality. Both 
IPC, as well as a PCMH intends to provide comprehensive, coordinated, and quality patient-
centered care. IPC also minimizes lack of communication between medical and mental health 
providers as they utilize the same location and medical record systems (Peikes, Zutshi, Genevro, 
Parchman, & Meyers, 2012).  
Access to care. Approximately 25% of adults visiting their PCP have a psychiatric 
disorder, and yet close to half of these cases go undetected (Roy-Byrne & Wagner, 2004). Onsite 
behavioral health providers can aid in improving detection rates and implementing prevention 
and early intervention. Integrating mental health services into the medical home, may reduce the 






2015). IPC can also help identify and treat populations experiencing mental health problems that 
may not otherwise seek or receive treatment. In traditional primary care settings, about 40% of 
patients are referred to specialty mental health, with only 10% of those individuals attending 
their first appointment (LaBrie et al., 2007). Whereas, an integrated primary care psychologist 
can increase access and follow-through rate, such that, of the roughly 70% of patients referred to 
attend behavioral health treatment, about 54% attend their first appointment (Miller-Matero et 
al., 2015). 
Satisfaction. Several studies have demonstrated increased satisfaction ratings among both 
patients and providers within an integrated primary care setting (Chen et al., 2006; Farrar, Kates, 
Crustolo, & Nikolaou, 2001). Past research has indicated that while physicians recognized the 
need for addressing the emotional well-being of patients, they also reported encountering 
difficulties with the referral process, as a result of the stigma often associated with psychiatry as 
well as lack of follow-through by patients (James, 2006; Morgan & Killoughery, 2003). A recent 
survey of family physicians found that those who had access to mental health services onsite 
reported a higher level of satisfaction and also identified increased communication, 
collaboration, and access to treatment as benefits of having mental health providers onsite 
(Kates, Fugere, & Farrar, 2004). Further, it has also been documented that providers feel an 
increased sense of comfort and confidence when assessing patient’s needs with regard to mental 
health, substance use, and suicide risk when having onsite behavioral health specialists with 
whom they may consult and collaborate (F. A. Blount & Miller, 2009). 
Quality of Treatment. Quality of delivery of healthcare is improved in IPC by also addressing 






problems (Prince et al., 2007). With regard to attending to mental health concerns, quality of 
patient care may be diminished as the process of referring and coordination between medical and 
mental health professionals can often be lengthy, causing aspects of professional and patient 
communication, as well as the referral itself, to be left incomplete. Behavioral health specialists 
can enhance patient care by assisting patients in implementing lifestyle and behavioral changes, 
including those recommended by their medical providers, to promote better management of 
chronic conditions and overall health (Miller, Mendenhall, & Malik, 2009). Further, consultation 
and collaboration among treatment providers under one treatment plan, as opposed to segregated 
care plans, aids in improving quality of care. Research demonstrates improved treatment 
outcomes, including decreased symptomatology, in integrated care systems as compared to 
traditional primary care systems (Hedrick et al., 2003; Zeiss & Karlin, 2008). 
Reduced costs. Collectively, depression and other mental illnesses rank as the third 
highest economic burden resulting from healthcare needs, after hypertension and heart disease 
(Goetzel et al., 2004). Estimates suggest that the total economic burden of depression is 
approximately $83.1 billion, 62 percent of which are related to workplace costs (Greenberg et al., 
2003). Thus, IPC can aid in facilitating overall reduction in healthcare costs and loss of 
workplace productivity by addressing mental health needs. Onsite behavioral health specialists 
can serve to increase medical clinic revenues by billing for patient care as well as alleviating 
medical providers from spending time on mental health issues, allowing them to see more 
patients (Miller et al., 2009). Mental health treatment offered through primary care tends to be 
less expensive for patients compared to specialty mental health services, which are often not 






Neuropsychology in Integrated Primary Care 
Although IPC is a relatively new field of practice, it is continually evolving to adapt to 
the patient-centered medical home. Given its infancy, research in IPC remains limited; however, 
more recent research has explored the role of neuropsychology in primary care (Kubu et al., 
2016; Michels et al., 2010). Neurocognitive impairment is a correlate of medical disorders, 
including liver disease, kidney disease, cardiac disease, and even more common diagnoses such 
as diabetes. Additionally, cognitive impairment has been identified as a barrier to successful 
treatment, because it adversely impacts a patient’s capacity to execute complex medical orders, 
maintain medication compliance, and provide appropriate information to medical staff. Given 
this growing awareness about cognitive health and disability has spurred a greater recognition of 
the value and import of neuropsychological assessment as a standard component of integrated 
medical care (Block, Johnson-Greene, Pliskin, & Boake, 2017).  
While the goals of neuropsychological assessment typically relate to the referral question, 
generally, neuropsychology can promote functional independence of patients, facilitate 
diagnosis, and help with patient care and treatment planning (Lezak, 2004). With regard to 
cognitive screening in primary care, practicing physicians have acknowledged the importance of 
recognizing and identifying cognitive impairment among their patient population, however, 
important barriers, such as added visit time, as well as uncertainty in administering diagnostic 
measures, still exist (Borson et al., 2007; Harvan & Cotter, 2006). Although there is not a 
singular instrument that has been denoted as the gold standard for cognitive screening, clinician 
surveys indicate that the Mini-Mental State Examination (MMSE) is the most widely used and 






regarding its sensitivity and vulnerability related to education, culture, and language of 
administration (Cullen, O’Neill, Evans, Coen, & Lawlor, 2007; Shulman et al., 2006). An 
additional issue related to the MMSE is its ceiling effect, which equates to a limited dynamic 
performance range for normal individuals. This increases the probability that individuals in pre-
dementia stages score within the normal range. The MMSE has been cited for having poor 
sensitivity for distinguishing mild cognitive impairment (MCI), likely attributed to a lack of 
complexity as well as the absence of executive function items (Trzepacz, Hochstetler, Wang, 
Walker, & Saykin, 2015).  
The Montreal Cognitive Assessment (MoCA) is another commonly used clinical 
instrument utilized in the screening of cognitive functioning. Past literature has found the MoCA 
to have superior sensitivity over the MMSE in detecting MCI. Reasons for this likely include 
more stringent cognitive assessment criteria such as more words in the memory testing, fewer 
learning trials, and a longer delay before recall than the MMSE. Additionally, the MoCA utilizes 
higher-level language abilities and complex visuospatial processing. Overall, the literature 
indicates that the MoCA’s increased sensitivity can be attributed to more numerous and 
demanding tasks than the MMSE. Nevertheless, it has been noted that the MoCA should only be 
utilized as a screening tool. The information gained from administering the MoCA should be 
used to provide quick guidance for referral and further, more comprehensive, investigation of 
potential cognitive impairment (Larner, 2012; Nasreddine et al., 2005). 
While the use of validated cognitive screening tools certainly informs and improves 
clinical practice for healthcare providers, screening measures were never intended to be used in 






Temple, Carvalho, & Tremont, 2006). Noted elsewhere, there exist tangible barriers to 
neuropsychological evaluation, not the least of which is the lengthy waitlist time that is common 
in urban healthcare centers nationwide and reliance on the process of patient referral and post-
evaluation record transmission, particularly with patients who may have cognitive impairment 
(Borson, Scanlan, Watanabe, Tu, & Lessig, 2006; Kubu et al., 2016; Temple et al., 2006). 
Ultimately, having access to onsite neuropsychological services may aid in alleviating some of 
these barriers. 
Subjective Cognitive Decline 
Identification of candidates for neuropsychological evaluation can result from numerous 
events – reported concern of a patient’s family member, clinical decision making by medical 
staff, and subjective report of cognitive change, among others. Subjective cognitive decline 
(SCD) in older adults is increasingly recognized as a possible sign of non-normative cognitive 
aging, which could eventually progress to a diagnosis of dementia (Rabin et al., 2015; Snitz, 
Morrow, Rodriguez, Huber, & Saxton, 2008). Recent research has shown an association between 
SCD and biomarkers as well as neuroimaging markers of Alzheimer’s disease (AD), in the 
absence of objective cognitive dysfunction or depression. Given research supporting SCD as a 
risk factor for AD in some individuals, the National Institute on Aging–Alzheimer’s Association 
preclinical AD working group has included SCD as a facet, emphasizing its importance in 
disease detection and prevention (Rabin et al., 2015). Further, the presence of subjective 






and as one of the general core and cognitive criteria for the early diagnosis of mild cognitive 
impairment (Juncos‐Rabadán et al., 2014).  
Subjective cognitive complaints are common in older adult patients, who typically 
present to their primary care providers. Thus, providers located in a primary care setting could 
play a critical role in the early detection of cognitive impairment. Further, the Alzheimer’s 
Association has recommended cognitive assessment in primary care settings, as a way to aid in 
reducing the prevalence of missed or delayed dementia diagnoses (Rabin et al., 2015). In a 
sample of older adult primary care patients (mean age 73.2) Snitz and colleagues (2008) found 
that self-reports of current memory ability were associated with objective memory performance. 
Further, in a study of older adult, community-dwelling volunteers, results indicated that 80% of 
individuals with MCI endorsed subjective memory complaints (De Jager & Budge, 2005).  
Subjective cognitive decline is assessed by self-report of cognition. This assessment 
approach is associated with advantages such as brevity, ease of administration, and low cost. 
However, past research has documented the disadvantage that, currently, the field lacks a single 
accepted approach in assessing SCD. These studies have cited the need for additional research to 
clarify the nature of the questions assessing functioning (present status versus decline), as well as 
cognitive domains of greatest interest, and optimal items for each domain (Rabin et al., 2015; 







The overall purpose of this study was to examine the effectiveness and feasibility of a 
brief neuropsychological battery, for memory concerns, in a community primary care setting. 
Specifically, we hypothesized that: 
Hypothesis 1: The number of neuropsychological referrals for the onsite clinic would be 
greater than those made previously for outside referrals (compared on a consistent nine-
month timeframe), on account of access to readily available onsite services.  
Hypothesis 2:  Accessibility of results of neuropsychological evaluations would increase 
as a result of onsite services. Accessibility was assessed by comparing presence of 
neuropsychology reports in the UCF Health EMR for those patients who received outside 
referrals, to the number of such reports for patients referred for integrated neurocognitive 
assessment. 
Hypothesis 3:  Scores on the measure of subjective cognitive decline would be 
significantly correlated with performance on measures of neurocognitive functioning. 
Specifically, it was hypothesized that SCD scores would correlate with an individual’s 
(Hypothesis 3A) RBANS Total Scale Score, (Hypothesis 3B) RBANS Delayed Memory 
subscale score, and (Hypothesis 3C) Trails B performance score.  
Hypothesis 4: Provider satisfaction with available neuropsychological services would 
increase as a result of having access to onsite neuropsychological services as measured 
by scores on the provider survey. Baseline satisfaction levels were measured prior to 
beginning onsite neuropsychological services and then compared to respondent scores 






CHAPTER 2: METHODS 
Study Participants 
 The present study utilized data from both patient participants and medical providers from 
an outpatient academic medical center. 
i. Patient Participants  
Participants were recruited from the patient population of an outpatient academic medical 
center providing both primary and specialty healthcare. Medical providers practicing at this 
medical center during the course of the study helped to identify patients who may have been 
experiencing cognitive difficulties (e.g., memory problems). Providers verbally informed 
patients of  the research study and if the patient was interested, entered a referral into the EMR 
system, which was routed to the study coordinators. Patients could also refer themselves to the 
study. Once the study coordinator received the patient’s information, the patient was then 
contacted to assess for appropriateness of study inclusion. Inclusion criteria included being 18-
years of age or older and demonstrated fluency in English. Prospective participants who had an 
existing diagnosis of dementia and/or Major Neurocognitive Disorder, Moderate or Severe, were 
excluded, unless accompanied by their healthcare proxy, who legally held medical power of 
attorney for the diagnosed individual and agreed to provide consent, while assent was attained 
from the patient. Additional exclusion criteria included individuals who were actively pursuing 
litigation related to their neurocognitive functioning and/or previously referred-for 
neuropsychological services. Patients who consented to participate in the study were then 






available to patients who did not meet study criteria or who elected not to participate in the 
study. 
Patients that met study criteria were then scheduled for an individual interview and 
neurocognitive evaluation. During this appointment, they were also given study information, 
provided informed consent, were interviewed about their cognitive functioning, and completed 
study questionnaires. After completing the testing session, participants were scheduled for a 
follow-up session, during which results and recommendations from their evaluation were 
reviewed. A total of 23 patients were referred for the study. Of those, 4 were unable to be 
reached and 3 declined services after further information was provided. A total of 16 participants 
enrolled in and completed the study. All study-related activity took place in the outpatient 
healthcare clinic and was approved by the University Institutional Review Board and clinic 
administration. 
ii. Medical Providers 
Medical providers who were practicing at UCF Health during the study were asked to 
participate in a provider survey assessing facets of satisfaction related to the availability of 
neuropsychological services. Both primary care and specialty care providers were invited to 
participate, including those who practice in cardiology, endocrinology, family medicine, 







iii. Previously referred patients 
Participants from UCF Health, who were previously referred for outside 
neuropsychological services from UCF Health, were also included in the study in order to 
ascertain the number of referrals made as well as to evaluate the absence or presence of a 
neuropsychological report contained within their medical record. No other information from their 
electronic medical record was accessed. Included participants in this subsample consisted of 
those who received a referral for neuropsychological assessment in the community between 
February 1, 2017 and October 31, 2017. 
iv. Proposed sample size – enrolled participants  
A thorough review of the literature suggests that, the practice of clinical neuropsychology 
is expanding in that there is no longer only limited interaction with other healthcare providers. 
Previous research has found that the role and value of clinical neuropsychology on integrated 
care teams is not confined to clinical assessments and has evolved to include a wide range of 
services provided to a diverse spectrum of healthcare teams (Kubu et al., 2016; Michels et al., 
2010). Studies have shown that primary care physicians found neuropsychological services to be 
useful; integrating information from the neuropsychological evaluation into their patient 
recommendations as well as physician discharge summaries (Temple et al., 2006). However, 
despite the well-documented utility of neuropsychological services within an integrated 
healthcare team, research on the feasibility of these services is lacking. Further, of the available 
research in this area, most studies do not separate the neuropsychological components (i.e., 






by Heinemann and colleagues (1995) found that, compared with physical, occupational, and 
speech therapy, neuropsychological services focused on remediating cognitive deficits resulted 
in significantly better functional outcomes for patients who had suffered either a traumatic brain 
injury or spin cord injury. Other studies have supported the fiscal-effectiveness of integrated 
neuropsychological services on healthcare teams (Aronow, 1987; Wolfs, Dirksen, Kessels, 
Severens, & Verhey, 2009). Thus, while there are some promising studies examining aspects of 
integrated neuropsychological services, additional studies are needed to elucidate the feasibility 
and efficacy of these services within an integrated healthcare team in a community primary care 
setting. 
The number of participants in the sample of clinical service providers was inherently 
limited by the number of respondents among the UCF medical staff. Other studies that have 
investigated aspects involving integrated neuropsychological services have had sample sizes 
ranging from 18 to 55 participants, in populations of individuals with traumatic brain injury 
(Conneeley, 2012) and HIV-associated neurocognitive disorder (Kamminga et al., 2017), 
respectively.  
Method 
v. Feasibility, efficacy, and accessibility 
Data investigating the feasibility, efficacy, and accessibility related to the onsite clinic 
was assessed with various approaches. More specifically, this included an analysis of the number 
of referrals made for outside neuropsychological services over a nine month period as well as the 






other information from the medical record was accessed, outside of if a referral was made and 
investigating whether or not a neuropsychological report had been scanned in and/or attached to 
their EMR). This data was provided via an honest broker (an individual from the UCF Health IT 
Team), to maximize the protection of patient PHI. 
vi.Patient Participants 
 Participants who consented to enroll in the study were scheduled for an evaluation and 
brief interview. The evaluation included testing measures that examined the participant’s 
neurocognitive functioning across domains of attention, language, visuospatial/constructional 
abilities, immediate and delayed memory, premorbid reading level, confrontation naming, and 
executive function. Components of current emotional status and perception of cognition were 
also examined via self-report measures completed by the participant. Once testing was 
completed, all materials were scored, and a brief report, describing their results and how these 
results compare to others of similar age, gender, and education level was composed. The primary 
goal of the report was to allow the participant and/or provider to gain a better understanding of 
the relationship of the participant’s scores to normal and abnormal cognitive performance. All  
reports were reviewed and signed by a licensed psychologist, prior to being placed in the 
participant’s medical record. Following this, a feedback session with the participant was 
scheduled, during which results and subsequent recommendations were reviewed, and the 
participant was given ample time to ask questions for clarification.  
Patient satisfaction with onsite clinic services was also measured, This was done with an 






ease of access regarding the onsite clinic, utility of services, adequate acknowledgement of 
presenting concerns, and helpfulness of feedback and subsequent recommendations. The survey 
was administered following the feedback session.   
vii.Medical Providers  
Data assessing provider satisfaction with available neuropsychological services was 
collected via an electronically distributed anonymous Qualtrics survey. They survey assessed 
facets of satisfaction related to the availability, utility, and usefulness of services. The survey 
was administered prior to the beginning of the proposed onsite clinic and again at the end of the 
trial period for this clinic, in order to better understand satisfaction related to neuropsychological 
services both before and after onsite services were implemented.  
Measures 
Demographic Variables. Participants provided information on the following demographic 
information.  
Age. Participants provided their date of birth.  
Sex. Participants identified their sex by indicating either male, female, or other.  
Ethnicity. Participants identified their ethnicity by indicating one of the following 
choices: African-American/Black; American Indian/Native Alaskan; Asian/Southeast 
Asian/Asian-American; Caucasian/European/White; Native Hawaiian/Other Pacific Islander; or 
Latino(a)/Hispanic. 






Existing diagnoses. Participants verified the accuracy of existing diagnoses within their 
medical records. 
Medications List. Participants verified the accuracy of current medications listed within 
their medical records via verbal confirmation of the listed information. 
Assessment Measures. 
Repeatable Battery for Neuropsychological Status (RBANS). The RBANS is a brief, 
individually administered test, which measures attention, language, visuospatial/constructional 
abilities, and immediate and delayed memory. The RBANS is comprised of 12 subtests, which 
generate five Index scores as well as a Total Scale score (Duff, Hobson, Beglinger, & O'Bryant, 
2010). Research has found the RBANS to be valid and reliable across age ranges and various 
populations, including neurological populations such as those who have suffered traumatic brain 
injury (TBI), stroke, and concussion, among others. The RBANS has demonstrated high internal 
consistency (0.88) and test-retest reliability (Randolph, 1998). 
 National Adult Reading Test (NART). The NART is a measure of premorbid 
functioning. It is a reading test comprised of 50 single word items of graded difficulty. The 
words are irregular, as they contradict typical grapheme-phoneme correspondence rules. The 
NART has demonstrated high internal consistency, test-retest reliability, and inter-rater 
reliability (0.90, 0.98, and 0.88, respectively) (Uttl, 2002). 
Boston Naming Test-II (BNT-II). The BNT-II is a confrontation naming task, which 
assesses an individual’s ability to retrieve different types of words. Confrontation naming can 
include pictures of objects, which tests noun retrieval or pictures of actions, which tests verb 






in word-finding abilities in individuals with various types of neurologic impairments (Spreen & 
Risser, 2003). The BNT-II is the most common test of confrontation naming (Kaplan, 
Goodglass, & Weintraub, 2001). This test requires an individual to identify line drawings of 
common man-made, as well as naturally occurring, objects. The BNT-II has demonstrated a high 
test-retest reliability (r = 0.91; (Morris et al., 1989; Welsh-Bohmer & Mohs, 1997). 
Reitan Trail Making Test, A and B. The trail making test is administered in two parts; 
A and B. For Part A, the subject is asked to draw lines connecting consecutively numbered 
circles on a worksheet. Part B asks that the subject connect consecutively numbered and lettered 
circles by alternating between the numbers and letters. The test-retest reliability is moderate to 
high for Part A (r=.36 to .79) and Part B (r=.44 to .89). In addition, inter-rater reliability has been 
found to be high for both Part A r=(.94) and Part B (r=.90) and content validity has been shown 
to correlate moderately between Part A and B (Reitan, 1958). 
Generalized Anxiety Disorder-7 (GAD-7): The GAD-7 is a self-report measure that 
assesses severity of symptoms associated with anxiety. The GAD-7 has been found to be a 
reliable and valid measure across several populations. It produces an overall score with cutoffs to 
identify points for mild, moderate, and severe symptoms associated with anxiety. The GAD-7 
has demonstrated good internal consistency (0.92), test-retest reliability (0.83), procedural 
validity, and construct validity (Mills et al., 2014).  
The Geriatric Depression Scale (GDS). The GDS is a self-report measure of depression 
in older adults, in which individuals respond in a “Yes/No” format. The GDS was originally 
developed as a 30-item instrument, however, since its initial version, a 15-item version was 






Scale-Long Form (GDS-L). The GDS-15 has been found to have good sensitivity and specificity 
for detecting depression (88% and 64% respectively), as well as high internal consistency (0.94; 
(Agrell & Dehlin, 1989; Sheikh & Yesavage, 1986)). Additionally, the GDS has been found to 
be a useful tool in medical settings, with medically complex patients given that there may be a 
high level of decreased activity, as well as those with comorbid cognitive impairment (Kieffer & 
Reese, 2002; Weintraub, Saboe, & Stern, 2007).  
Everyday Cognition, Self-Report Form (ECog). The ECog is a multidimensional, 
psychometrically sound measure of everyday function in older adults. The ECog measures 
everyday function in multiple domains (memory, language, visual-spatial and perceptual 
abilities, executive functioning (planning, organization, and divided attention)). The ECog has 
been found to be a reliable and valid measure across groups of normal aging, those with mild 
cognitive impairment, and those with a diagnosis of dementia (α = .96, test-retest reliability, r = 
.82, p < .0001; (Farias et al., 2008)). 
Provider Satisfaction Survey. Providers were asked to complete a provider experience 
survey to evaluate components of satisfaction related to having access to onsite integrated 
neuropsychological services at UCF Health. The survey was created for purposes of the current 
study, however, existing surveys were referenced when creating the current provider satisfaction 
survey (Hine et al., 2017). The survey consists of 9 statements assessing varying domains of 
satisfaction related to neuropsychological services (e.g., “Neuropsychological services that are 
available to my patients have been very useful in determining diagnoses”; “When referred, my 
patients have been able to schedule neuropsychological evaluations in a timely manner”; “The 






and “Results of neuropsychological evaluations have helped to inform my practice and patient 
care.”). Providers rate their agreement with these 9 statements on a 5-point Likert scale from 1 
(Strongly Disagree) to 5 (Strongly Agree). The survey also includes one question, asking 
providers to rate their overall satisfaction with neuropsychological services (0 = Not at all 
satisfied, 10 = Completely satisfied). Lastly, the survey asks two open-ended questions allowing 
providers to identify the most and least helpful aspects related to neuropsychological services.   
Patient Satisfaction Survey. Participants were asked to complete a patient experience 
survey to evaluate components of satisfaction related to receiving integrated neuropsychological 
services at UCF Health. The survey was created for the current study purposes, however, survey 
items were adapted from existing patient satisfaction measures (Ede et al., 2015). The survey 
consists of 11 statements assessing varying domains of the onsite clinic (e.g., “Any concerns I 
may have had regarding my cognitive status were addressed quickly”; “Testing and results were 
provided to me in a language or way I could easily understand”; “I feel I was provided with 
helpful recommendations to address my cognitive concerns”; and “I feel that feedback supplied 
by my cognitive health specialist, to my medical provider, was helpful in coordinating my 
care.”). Participants rate their agreement with these 11 statements on a 5-point Likert scale from 
1 (Strongly Disagree) to 5 (Strongly Agree). The survey also includes one question, asking 
participants to rate their overall satisfaction with the onsite clinic (0 = Not at all satisfied, 10 = 
Completely satisfied). Lastly, the survey asks two open-ended questions allowing participants to 







Descriptive statistics were employed to characterize sub-samples of participants as well 
as medical providers. Comparisons examining the number of neuropsychological referrals were 
done using Chi-square statistics for categorical variables (hypothesis 1). Comparisons examining 
the accessibility of neuropsychological reports were made using Chi-square statistics for 
categorical variables (hypothesis 2). Associations between measures of objective cognitive 
performance and subjective cognitive decline scores were tested using bivariate Pearson 
correlations (hypothesis 3). Analyses examining the relationship between subjective and 
objective cognitive performance were performed both with and without inclusion of the GDS-15 
depression score and years of education as control variables. An additional analysis examining 
participants’ satisfaction with the onsite clinic was addressed using descriptive statistics. 
Comparisons between pre- and post- levels of provider satisfaction were made using an 







CHAPTER 3: RESULTS 
Feasibility, efficacy, and accessibility 
The number of neuropsychological referrals made during the time of the onsite clinic was 
compared to that of the same length, prior to the start of the onsite clinic. To ascertain whether a 
difference was present in the number of referrals made during the time of the onsite 
neurocognitive clinic (September 2018 – May 2019) and those made in a nine-month period 
prior to the start of onsite services (February 2017 and October 2017), a Pearson chi-square was 
conducted. More specifically, in total, 23 referrals were made to the onsite clinic, with 16 
patients enrolling as study participants. The number of enrolled study participants (16) was 
significantly more than the 10 referrals that had been made in the nine-month period for outside 
neuropsychological services, prior to the start of this study (χ2(1) = 26.00, p < .001, V = 1.00). 
Regarding accessibility of neuropsychological reports, an additional chi-square was conducted to 
compare the accessibility of reports during the onsite clinic as compared to those that had been 
referred for outside neuropsychological services, prior to the commencement of the onsite clinic. 
For those who had received services at the onsite neurocognitive clinic, the number of reports 
located within the patient’s EMR was significantly greater than those who had received outside 
services (χ2(1) = 22.02, p < .001, V = .92).   
Patient Participants 
A total of 16 participants enrolled in and completed the study. As displayed in Table 1, 






(93.8%), partnered (75.0%), and cohabitated with another individual (75.0%). Participants had 
an average of 17.25 years of education and 2.38 medical diagnoses.  
A reliability analysis was conducted for each domain of the subjective cognitive decline 
measure. These analyses revealed high internal consistency across all domains, including 
memory, which consisted of 8 items (α = .94); language, which was comprised of 9 items (α = 
.96); visuospatial, which included 7 items (α = .97); and executive function, which contained 15 
items (α = .98). Following this, associations between subjective cognitive decline and scores on 
measures of neurocognitive function were tested using bivariate Pearson correlations (see Table 
2). Assumptions of bivariate normality were assessed visually utilizing a scatterplot of the data 
points. Results revealed that subjective cognitive decline scores as well as scores on objective 
measures of cognitive performance, including the RBANS Total Scale Score, RBANS Delayed 
Memory Index Score, and Trails B violated the assumptions of bivariate normality. Thus, square 
root transformations were performed on the data, in an effort to normalize the data (Tabachnick 
& Fidell, 2013). This transformation eliminated the violation of bivariate normality for 
subjective cognitive decline and objective cognitive performance scores. Results did not indicate 
a significant correlation between subjective cognitive decline scores and RBANS Total Scale 
Scores (r(14) = .20, p = .46); subjective cognitive decline and RBANS Delayed Memory Index 
Score (r(14) = .06, p = .84); or subjective cognitive decline and Trails B performance (r(14) = -
.02, p = .94). Additional analysis with the inclusion of GDS-15 depression scores and years of 
education as control variables were also performed (see Table 3). Results from these analyses did 
not indicate a significant correlation between subjective cognitive decline scores and RBANS 






Memory Index Score (r(12) = .01, p = .99); or subjective cognitive decline and Trails B 
performance (r(12) = -.32, p = .27). A post-hoc analysis was conducted with the inclusion of 
GAD-7 scores and years of education as control variables. Results from these analyses also did 
not indicate a significant correlation between subjective cognitive decline scores and RBANS 
Total Scale Scores (r(12) = .06, p = .83); subjective cognitive decline and RBANS Delayed 
Memory Index Score (r(12) = -.03, p = .93); or subjective cognitive decline and Trails B 
performance (r(12) = -.42, p = .14). 
In order to better understand the relationship between subjective cognitive decline and 
neurocognitive function among participants, auxiliary analyses, examining the relationship 
between specific domains of subjective cognitive decline (e.g., executive function), as measured 
by the Ecog, and corresponding measures of neurocognitive functioning (i.e., Trails B) were also 
performed. Results did not indicate a significant correlation between subjective cognitive decline 
of language and BNT Scores (r(14) = .09, p = .75); COWAT scores (r(14) = -.15, p = .58); or 
RBANS Semantic Fluency (r(14) = .28, p = .30); nor between subjective cognitive decline of 
visuospatial skills and RBANS Figure Copy (r(14) = .06, p = .82), or RBANS Visuospatial Index 
Score (r(14) = .04, p = .88). Results also did not indicate a significant correlation between 
subjective cognitive decline of memory and RBANS Delayed Memory Index Score (r(14) = .15, 
p = .59) nor between subjective cognitive decline of executive function and RBANS Coding 
(r(14) = .29, p = .26) or Trails B (r(14) = -.01, p = .96; see Table 4). 
 Participant satisfaction was measured from 15 participants (the final participant has not 
yet returned for their feedback session). Survey results revealed that, overall, participants were in 






with the amount of time the cognitive health specialist spent with me during my visit (M = 4.87, 
SD = 0.35); (2) My beliefs about my health and well-being were considered as part of the 
services that I received (M = 4.73, SD = 0.59); (3) I would follow through if I were referred 
outside this clinic for neuropsychological testing services (M = 4.67, SD = 0.62); (4) Any 
concerns I may have had regarding my cognitive status were addressed quickly (M = 4.60, SD = 
0.63); (5) Testing and results were provided to me in a language or way I could easily understand 
(M = 4.93, SD = 0.26); (6) I am comfortable receiving cognitive health services here at this clinic 
(M = 4.60, SD = 1.06); (7) I am treated the same as other people who get care at the clinic (M = 
4.73, SD = 0.70); (8) I prefer to receive my cognitive health services at the location where I 
receive my medical care (M = 4.80, SD = 0.56); (9) I feel I was provided with helpful 
recommendations to address my cognitive concerns (M = 4.93, SD = 0.26); (10) I feel that 
consultation between my medical provider and cognitive health specialist was helpful to me (M = 
4.80, SD = 0.56); and (11) I feel that feedback supplied by my cognitive health specialist, to my 
medical provider, was helpful in coordinating my care (M = 4.53, SD = 0.83). Participants 
reported overall satisfaction with the services of the onsite clinic (M = 9.80, SD = 0.56). Please 
refer to Figure 2 for depiction of results.  
Medical Providers 
 In total, nine satisfaction surveys were returned; with six having been completed at the 
pre-survey and three at the post-survey. It should be noted that, as the survey was submitted 
anonymously, it is not possible to confirm that the same providers submitted responses for the 






was a statistically significant difference in the mean of the pre-survey overall satisfaction level 
and post-survey overall satisfaction level among medical providers. Homogeneity of variance 
was assessed using Levene’s test for equality of variances and this assumption was met for the 
analysis (p > .05). Results revealed a significantly higher level of overall satisfaction with 
neuropsychological services following the onsite clinic (post-survey; M = 8.67, SD = 1.16) than 
indicated prior to the start of onsite services (pre-survey; M = 5.83, SD = 1.84; t(7) = -2.40, p = 
.04). Despite this, an aspect that must be acknowledged is the marginal statistical power 
associated with these analyses, due to the limited sample size, and results should not be 
overinterpreted. Nevertheless, medical providers endorsed significantly higher levels of 
satisfaction at post-survey related to the following components: (1) timely scheduling of referred 
patients for neuropsychological services (t(7) = -12.98, p < .001); (2) timely completion of 
reports following patient appointment (t(7) = -2.59, p = .04); (3) ease of accessibility of 
neuropsychological reports (t(7) = -2.59, p = .04); (4) interaction with neuropsychological 
providers (t(7) = -3.36, p = .01); and (5) availability of neuropsychological services (t(7) = -3.46, 







CHAPTER 4: DISCUSSION 
 The primary purpose of this study was to evaluate efficacy and feasibility related to the 
implementation of an onsite neurocognitive clinic within an outpatient academic healthcare 
setting. Overall, results supported hypothesis 1, with an increased number of neuropsychological 
referrals for the onsite clinic in comparison to those made for outside neuropsychological 
services during a nine-month period. Hypothesis 2 was also supported, as accessibility of 
neuropsychological evaluations located in the EMR increased for those who received onsite 
services, when compared to those who had received outside referrals. No significant correlations 
were found between subjective cognitive decline scores and measures of neurocognitive 
functioning, including RBANS Total Scale Score, RBANS Delayed Memory Index score, and 
Trails B performance. Results were also insignificant when controlling for years of education 
and GDS-15 scores as well as for a post-hoc analysis which included GAD-7 scores and years of 
education as control variables. Satisfaction survey results revealed that, overall, participants were 
satisfied with and found onsite services to helpful. Medical provider satisfaction was 
significantly higher following implementation of the onsite clinic than indicated at baseline 
levels, which were measured prior to the start of onsite services. Medical providers identified 
increased overall satisfaction, as well as satisfaction related to timely scheduling of referred 
patients, timely completion of and access to neurocognitive reports, as well as interaction with 
neuropsychological providers. However, the limited sample size and marginal statistical power 
associated with analyses surrounding provider satisfaction are important caveats to interpretation 






 Analyses did not find a significant correlation between measures of subjective cognitive 
decline and performance on objective measures of neurocognitive performance. Additional 
auxiliary analyses of SCD and objective test performance via specific domains (e.g., executive 
function and Trails B), were also non-significant. One possible reason for non-significant results 
may be due to the small sample size of the current study. Overall, the literature on the 
relationship between subjective cognitive decline and objective test performance presents highly 
varied findings, characterizing a complex relationship between SCD and objective cognitive 
performance. Snitz and colleagues (2008) found that self-reports of current memory ability were 
associated with objective memory performance in a sample of older adult patients in a primary 
care setting. Similarly, Rattanabannakit et al. (2016) found that participant and informant ratings 
of cognitive impairment were associated with objective scores on cognitive measures, even after 
adjusting for demographic variables and depressive symptoms. Conversely, Zlatar and 
colleagues (2017) did not find a significant association between SCD and objective cognition, 
after adjusting for both demographics and depression, in a sample of older adults referred for 
memory concerns. Additional studies have revealed similar findings to that of Zlatar et al. 
(2017), in that SCD was not significantly associated with objective cognitive measures, 
particularly after controlling for mood and demographic variables , and suggest that subjective 
cognitive complaints are less likely to be related to co-occurring cognitive impairment, and more 
likely related to depressive symptoms (Alegret et al., 2015; Balash et al., 2013; Zlatar, Moore, 
Palmer, Thompson, & Jeste, 2014). Further, Burmester, Leathem, and Merrick (2016) conducted 
a meta-analysis investigating how subjective cognitive complaints might reliably indicate 






association between subjective cognitive complaints and objective cognitive function, with 
stronger links between subjective complaints and depressive symptoms. It is possible that the 
results of the current study may serve as additional evidence in this complex relationship, though 
limitations related to samples size and subsequent statistical power should be acknowledged.  
 An additional possibility for the non-significant findings between SCD and objective 
neurocognitive data may also be related to the particular group of patient participants. More 
specifically, it is possible that our patient participants represent a group more consistent with 
those who have been previously referred to as the “worried well,” which describes patients who 
are hypersensitive to and anxious about memory changes, but do not show objective findings on 
neuropsychological testing (Kinzer & Suhr, 2016; Thompson, Henry, Rendell, Withall, & 
Brodaty, 2015). These “worried well” patients are likely to interpret everyday cognitive lapses as 
an indication of decline or impairment in memory (Kinzer & Suhr, 2016). It is also possible that 
individuals presenting with the primary concern of memory impairment or potential dementia, 
may not provide an altogether accurate report of their current neurocognitive functioning (Kinzer 
& Suhr, 2016). These positions highlight the findings of previous studies that have indicated the 
likelihood of individuals presenting with SCD representing the “worried well,” rather than those 
with true impairment (Amariglio et al., 2012).Although results of a post-hoc analysis did not find 
a significant correlation between SCD and objective test scores when controlling for GAD-7 
scores and years of education, considerations surrounding limited sample size should be taken 
into consideration. In addition, the GAD-7 was designed as a screening tool to assess symptom 
severity. While the brevity of the GAD-7 facilitates an efficient approach to tracking symptoms 






cognitive symptoms or difficulty with cognitive functioning. Future research may aim to further 
assess anxiety related to perception of current cognitive difficulties during the interview with the 
patient to gain a better understanding of the impact this may have on subsequent results. Further, 
as past studies have also shown an association between negative stereotypes about age-related 
cognitive decline and subsequent decreased performance on neurocognitive measures (Arnett, 
2013; Barber & Mather, 2014; Suhr & Kinkela, 2007), future research may also aim to account 
for the possibility of this stereotype threat, which may influence the relationship between SCD 
and objective test performance. 
A strength of the current study includes the increased satisfaction levels among medical 
providers related to onsite neurocognitive clinic services. Moreover, satisfaction levels for the 
clinic were high among both medical providers and patient participants. Despite this, the referral 
rate for clinic services was generally slow throughout the study. While the clinic was rated as 
providing useful, beneficial services, and was largely well-liked by both patients and providers, 
the overall low referral rate reflects an underutilization of clinic services in this particular 
application. Extant literature suggests that, as a whole, neuropsychology’s integration into 
primary care settings, and onto integrated care teams, has not happened quickly (Festa, 2018; 
Ruchinskas & Cullum, 2018). In a community based academic hospital system, the integration of 
neuropsychology into primary care clinics required a six-month timespan to resolve logistic 
hurdles alone (e.g., available space, referral flow); as well as an additional six-month time period 
following implementation, during which guidelines were established to inform appropriateness 
of referrals and the subsequent referral stream was better developed and refined (Lanca, 2018). 






is generally quite well received, with high levels of satisfaction with neuropsychology indicated 
by other team members (Kubu et al., 2016; Lanca, 2018; Ruchinskas & Cullum, 2018). With 
ample time, it appears that similar clinics offering neuropsychological services, and operating 
within primary care settings, have overcome difficulties with low referral rates and are largely 
well utilized, employing waitlists that span several weeks to several months out (Lanca, 2018; 
Lanca & Meisinger, 2019; Ruchinskas & Cullum, 2018).  
The results of the current study suggest multiple ways in which integrated 
neuropsychological assessment improves access to and quality of delivered health care. The 
Alzheimer’s Association has recommended cognitive assessment in primary care settings, as a 
way to aid in reducing the prevalence of missed or delayed dementia diagnoses. Research 
indicates that providers located in a primary care setting play a critical role in the early detection 
of cognitive impairment, as older adults with subjective cognitive complaints typically present 
first to their primary care providers (Rabin et al., 2015). Additionally, early cognitive decline is 
associated with greater use of primary care services (Fowler et al., 2012; Ganguli et al., 2004). 
Thus, there is a clear need for cognitive assessments that are both accessible and efficient within 
a primary care setting to meet the needs of this growing patient population. Integrating 
neuropsychological testing into primary care improves access for patients and allows primary 
care teams to incorporate neuropsychological results into subsequent case conceptualization, 
diagnosis, and patient care (Lanca, 2018; Lanca & Meisinger, 2019; Ruchinskas & Cullum, 
2018). As the current study documented directly in the EMR, neurocognitive reports were easily 






patient. Onsite clinic services allowed for greater access to cognitive assessments, as well as 
improved awareness and management of cognitive symptoms for both patients and providers. 
Despite the general findings related to increased referrals, accessibility of neurocognitive 
reports, and satisfaction with services, several barriers to the feasibility of a clinic of this nature 
were present. Although onsite clinic services were co-located in the primary care setting, it is 
possible these services were not viewed as being fully part of the integrated services available to 
patients and providers, This may have been due to the lack of availability of daily services (e.g., 
neurocognitive evaluations only scheduled two days per week) as well as services being 
delivered by a Master’s level trainee. While these components are consistent with the nature of a 
research study, it is possible that these factors limited the extent to which clinic services and 
providers were viewed as a part of the integrated care team. In addition, numerous structural 
changes occurred throughout the course of this study, including migration to a new EMR system. 
During the transition to the new EMR system, several internal processes were disrupted 
including the process by which referrals are initiated and processed in the EMR system. Due to 
the period of time this functionality was inaccessible, it likely affected referral rate during that 
timeframe. Future studies may aim to incorporate supplemental methods for referrals during an 
EMR transition when the referral system is compromised. This could include frequent check-in 
with providers or in-session consultation with patients during their medical appointment. It is 
possible that this approach, akin to a “warm handoff,” would  moderate the decrease in referrals 
and subsequent productivity of such a clinic. Additionally, several personnel changes transpired 
while the study was ongoing, including the loss of medical providers along with the addition of 






providers were unaware of onsite services, despite study coordinator’s best efforts to consistently 
remind providers of the onsite clinic. Research has indicated the importance of continually 
providing education to medical providers about the benefits and usefulness of neuropsychology 
as well as the ways that neuropsychologists can participate in patient care. Efficient assessments 
and feasible recommendations for patients can provide helpful information for medical providers 
and improve overall patient care (Festa, 2018; Lanca, 2018; Mercury, Kehoe, & Tschan, 2007). 
As staffing changes in health centers are common, future research should consider utilizing 
regular education sessions for medical providers, perhaps during monthly provider meetings or 
grand rounds. This could serve to not only remind current providers about the presence and 
utility of onsite services, but would also ensure that new providers were aware of such services, 
while also mitigating the potential loss of referrals. Perhaps the most significant change that 
occurred during the study timeframe included the dissolution of the behavioral health team. The 
Director of the behavioral health team made repeated efforts to increase awareness of clinic 
services, as well as the benefit to both patients and providers. It is expected that the conclusion of 
behavioral health services greatly impacted potential referrals. Overall, the multitude of 
structural changes that took place during the course of the study created an inherent threat to the 
rate of referrals.  
There are several limitations associated with the current study. One such limitation 
includes the small sizes of the participant and medical provider samples. There are currently 14 
medical providers at the location where the study was conducted, whose areas of practice span 
internal medicine, family medicine, cardiology, rheumatology, orthopedics, endocrinology, 






there was limited power to detect significant statistically significant results. Unfortunately, small 
sample size remains a direct challenge to current standards of design and analytic approaches 
(Etz & Arroyo, 2015). With regard to garnishing additional participation from medical providers, 
future research should aim to incorporate several ways in which providers may participate in 
measures that will add value to the study. For example, it is possible that certain providers prefer 
to fill out a paper and pencil survey, rather than utilizing an online modality, which could be 
circulated at a monthly provider meeting, in order to increase response rate. As noted previously, 
an additional limitation of this study pertains to the difficulties that were present in recruitment 
throughout the study. As previous research has indicated the substantial amount of time that has 
been required to successfully integrate neuropsychological services into a primary care setting, it 
is possible that, with additional time and resources, the slow rate of referrals of the current study 
may have resolved. Therefore, future research should aim to have sufficient time in which 
aspects related to logistics, referrals, and charting can be fully developed and appropriately 
flushed out. Future studies may also include a predetermined method in which new medical 
providers are automatically notified of clinic services and the way in which they may refer a 
patient through the EMR system. Lastly, the current study is also limited by the lack of diversity 
among the patient participants. This inherently limits the extent to which results, particularly 
those concerning subjective cognitive decline and objective neurocognitive performance, can be 
generalized to other populations. Future research should aim to include a more representative 
sample, whose results may generalize more broadly and to culturally diverse populations. 
As medical treatment continues to work toward a model that aims to improve the quality 






result, cognitive assessment services have become a part of the growing services that are 
accessible within primary care settings (A. Blount et al., 2007; Lanca, 2018). Subsequently, this 
has also facilitated recognition that cognitive health is a critical component to overall health and 
wellbeing and that detection of cognitive difficulties improves treatment efficacy. The value of 
neuropsychology on integrated care teams can be seen in a multitude of capacities. 
Neuropsychologists possess a unique expertise, in which their knowledge encompasses 
functional neuroanatomy, assessment, and behavior, along with clinical skills that are 
fundamental in working with patients (Festa, 2018; Kubu, 2018). Neuropsychologists are able to 
address likely barriers to compliance and evaluate cognitive, emotional, behavioral, and 
psychosocial facets, all of which  contribute to improved patient outcomes (Festa, 2018). The 
current study provides additional support for the value of neuropsychological integration into a 
primary care setting. Despite a slow referral stream, onsite neurocognitive services allowed for 
increased accessibility for both patients and providers and also served as a primary source of 
education for patients regarding cognitive symptoms, behavioral components, and subsequent 
recommendations. Extant literature indicates that memory disorder clinics are a growing service, 
and highlights the importance of neuropsychologists serving in such a role, where they have the 
opportunity to deliver these essential services to a patient and, oftentimes, their family. The 
current study offers several insights into the complexities associated with both the efficacy and 
















Figure 1: Participant Sample Selection 
  
23 patients referred for 
services 
19 patients 
16 participants enrolled in 
and completed the study 
4 patients were unreachable following 
multiple contact attempts 









Figure 2: Participant Satisfaction Data 
  
1 2 3 4 5
Satisfied with time spent with me during my visit
My beliefs about my health were considered
I would follow through with outside referral
My cognitive concerns were addressed quickly
Tests and results easy were to understand
I am comfortable receiving services at this clinic
Treated the same as others receiving care here
Prefer cognitive & medical services at same clinic
I was provided with helpful recommendations
Consultation between providers was helpful
Feedack to my physician about cognition was helpful
Overall Satisfaction
Strongly                                                                        Strongly





















Figure 3: Medical Provider Satisfaction Data 




1 2 3 4 5
NP services have been  useful in diagnoses
My patients will  follow up with NP referrals
My patients can schedule timely NP evals***
Timely reports have been provided*
I can easily gain access to patient's NP reports*
Satisfaction with interaction with np providers**
Results of NP evals have informed my practice
NP evals have facilitated diagnoses
Satisfaction with the NP services available**
Overall Satisfaction*
Strongly                                                                            Strongly































Table 1: Participant demographics. 
  
  Patient Participants 
  n = 16 
  
Variable  M (SD) 
Age 67.75 (10.47) 
Education (years) 17.25 (12.69) 
Number of Medical Diagnoses 2.38 (1.46) 
GAD-7 Total Score 6.00 (4.47) 
GDS-15 Total Score 4.44 (2.92) 
  
 Percentage of Sample 
Gender  
     Male 43.7 
     Female 56.3 
Race  
     Caucasian  93.8 
     Hispanic/Latino 6.2 
Partnership Status  
     Partnered 75.0 
     Unpartnered 25.0 
Cohabitation Status  
     Cohabitates 75.0 








Table 2: Bivariate Pearson correlations examining the relationship between subjective cognitive 
decline and neurocognitive domains. 
 
   
Neurocognitive Measure Ecog Total Score p 
Trails B 0.02 0.94 
RBANS Delayed Memory Index 0.06 0.84 
RBANS Total Scale Score 0.20 0.46 







Table 3: Partial correlations examining the relationship between subjective cognitive decline and 
neurocognitive domains, while controlling for education and GDS-15 scores. 
 
    
Neurocognitive Measure Ecog Total Score p  
Trails B -0.32 0.27  
RBANS Delayed Memory Index 0.01 0.99  
RBANS Total Scale Score 0.04 0.89  








Table 4: Auxiliary bivariate Pearson correlations examining the relationship between specific 
domains of subjective cognitive decline and corresponding neurocognitive performance. 
 
   
Neurocognitive Domain and Subtest Ecog Domain Score p 
Language   
     BNT 0.09 0.75 
     COWAT -0.15 0.58 
     RBANS Semantic Fluency 0.28 0.30 
Visuospatial   
     RBANS Figure Copy 0.06 0.82 
     RBANS Visuospatial Index Score 0.04 0.88 
Memory   
     RBANS Delayed Memory Index Score 0.15 0.59 
Executive Function   
     Trails B -0.01 0.96 
     BRBANS Coding 0.29 0.26 
















SCREENING INFORMATION FOR BRIEF NEUROCOGNITIVE EVALUATION 
 
 
Patient Name:   




1. Were you born in the United States? 
2. If you were born outside of the United States, did you attend high school in the U.S.? 
3. What language was primarily spoken in the home while you were growing up? 
4. Have you ever received a diagnosis related to your cognitive functioning (i.e., dementia, 
Major Neurocognitive Disorder)? If so, is your healthcare proxy here with you? 
5. Are you currently involved in any ongoing litigation related to your neurocognitive 



























Word Pronunciation Score 
(0/1) 
CHORD kɔːd  
ACHE eɪk  
DEPOT ˈdɛpəʊ  
AISLE aɪl  
BOUQUET buˈkeɪ  
PSALM sɑːm  
CAPON ˈkeɪpɒn, ˈkeɪpən  
DENY dɪˈnaɪ  
NAUSEA ˈnɔːziə, ˈnɔːsiə  
DEBT det  
COURTEOUS ˈkɜːtiəs  
RAREFY ˈrɛərɪˌfaɪ  
EQUIVOCAL ɪˈkwɪvəkəl), ɪˈkwɪvəkl  
NAÏVE naɪˈiːv  
CATACOMB ˈkætəˌkəʊm, ˈkætəˌkuːm  
GAOLED dʒeɪld  
THYME taɪm  
HEIR ɛə, eə(r)  
RADIX ˈreɪdɪks  
ASSIGNATE ˈæsɪɡneɪt  
HIATUS haɪˈeɪtəs  
SUBTLE ˈsʌtəl, ˈsʌtl  
PROCREATE ˈprəʊkrɪˌeɪt, ˈprəʊkrieɪt  
GIST dʒɪst  
GOUGE ɡaʊdʒ  
SUPERFLUOUS suːˈpɜːflʊəs, suːˈpɜːfluəs, sjuːˈpɜːfluəs  
SIMILE ˈsɪmɪlɪ, ˈsɪməli  
BANAL bəˈnɑːl  
QUADRUPED ˈkwɒdrʊˌpɛd, ˈkwɒdruped  






FAÇADE fəˈsɑːd, fæˈsɑːd  
ZEALOT ˈzɛlət  
DRACHM dræm  
AEON ˈiːən, ˈiːɒn  
PLACEBO pləˈsiːbəʊ  
ABSTEMIOUS əbˈstiːmɪəs, əbˈstiːmiəs  
DÉTENTE deɪˈtɑːnt, French detɑ̃t  
IDYLL ˈɪdɪl  
PUERPERAL pjuːˈɜːpərəl  
AVER əˈvɜː, əˈvɜː(r)  
GAUCHE ɡəʊʃ  
TOPIARY ˈtəʊpɪərɪ, ˈtəʊpiəri  
LEVIATHAN lɪˈvaɪəθən, ləˈvaɪəθən  
BEATIFY bɪˈætɪˌfaɪ, biˈætɪfaɪ  
PRELATE ˈprɛlɪt, ˈprelət  
SIDEREAL saɪˈdɪərɪəl, saɪˈdɪəriəl  
DEMESNE dɪˈmeɪn, dɪˈmiːn, dəˈmeɪn  
SYNCOPE ˈsɪŋkəpɪ  
LABILE ˈleɪbɪl  




Total Errors: ______________ 
 
 
Total Errors Premorbid VIQ Estimate Classification Range 
0 – 11  120 – 129  Superior 
12 – 19  110 – 119  High Average 
20 – 36 90 – 109 Average 
37 – 45  80 – 89 Low Average 






































































































































































I am satisfied with the amount of time the 
cognitive health specialist spent with me 
during my visit. 
1 2 3 4 5 
My beliefs about my health and well-being 
were considered as part of the services that I 
received. 
1 2 3 4 5 
I would follow through if I were referred 
outside this clinic for neuropsychological 
testing services. 
1 2 3 4 5 
Any concerns I may have had regarding my 
cognitive status were addressed quickly 
1 2 3 4 5 
Testing and results were provided to me in a 
language or way I could easily understand. 
1 2 3 4 5 
I am comfortable receiving cognitive health 
services here at this clinic. 
1 2 3 4 5 
I am treated the same as other people who get 
care at the clinic. 
1 2 3 4 5 
I prefer to receive my cognitive health 
services at the location where I receive my 
medical care. 
1 2 3 4 5 
I feel I was provided with helpful 
recommendations to address my cognitive 
concerns. 
1 2 3 4 5 
I feel that consultation between my medical 
provider and cognitive health specialist was 
helpful to me. 
1 2 3 4 5 
I feel that feedback supplied by my cognitive 
health specialist, to my medical provider, was 
helpful in coordinating my care. 
1 2 3 4 5 
 
 






(0 = Not at all satisfied, 10 = Completely satisfied) 
 






































Neuropsychological services that are 
available to my patients have been very 
useful in determining diagnoses. 
1 2 3 4 5 
My patients will usually follow up when 
referred for neuropsychological evaluations. 
1 2 3 4 5 
When referred, my patients have been able to 
schedule neuropsychological evaluations in a 
timely manner. 
1 2 3 4 5 
The available neuropsychological services 
provide timely reports after my patients have 
been seen. 
1 2 3 4 5 
Once my patients complete 
neuropsychological referrals, I can easily 
gain access to their reports. 
1 2 3 4 5 
I am satisfied with the level of interaction 
with neuropsychological providers. 
1 2 3 4 5 
Results of neuropsychological evaluations 
have helped to inform my practice and 
patient care. 
1 2 3 4 5 
Neuropsychological evaluations have 
facilitated diagnosis of my patients. 
1 2 3 4 5 
I am satisfied with the neuropsychological 
services that have been available to my 
patients. 
1 2 3 4 5 
 
 
How would you rate your overall satisfaction of this service? __________ 
(0 = Not at all satisfied, 10 = Completely satisfied) 
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